All Type of News
Reference pricing drug groups remarkably scaled down.
The reference pricing system seems to be remarkably reduced in its therapeutic groups on the contrary to the earlier projection.
In the explanatory meeting with relevant organizations on June 25 the MOHW made it ...
KPA concentrates on Eradication of collusion, Prescription by generic name
KPA decided to devote all their energy to carry out eradication of prearranged trade, prescription by generic name and rationalization of pharmacy insurance medical charge.
Chairman Han Seok-won of KPA said that ...
KPA stands strongly against a farfetched assertion of Optional Medical System
KPA settled that they will strongly cope with forced assertion of medical circles bringing up enforcement of optional medical system.
KPA defined advertisement 'Give rights to choose to the people, Optional medi...
Pharmacy Establishment but Pharmacist will be settled after consultation with MOHW
Korea Fair Trade Commission expressed the position that establishment of pharmacy but pharmacist will be decided after due consultation with Ministry of Health and Welfare.
KFTC was quoted as saying, "its problem ...
Doctors go into Shortened Medical examination, keeping rejection against Government's notice
Medical circles go into shortened medical treatment as part of rejection struggle against Government's financial stabilization measure from today (July 9).
Shortened medical examination treating patients from 9 a.m...
Clinic-leveled Healthcare institutions are shrinking
The rising healthcare institutions on the level of clinic are shrinking.
The survey totalized by National Health Insurance Corporation shows that there are total 38,702 clinics now opening at the beginning of June...
KPMA supports Managerial Consulting of Pharmaceutical Manufacturing Companies
KPMA plans to strengthen membership service including providing managerial consulting across overall management area such as managerial strategy, organization and personnel innovation, wage system innovation to member...
Mounting problems lie ahead of medical reform program.
The revised bill of the pharmaceutical affairs law failed to pass through but put it to the next special session of the National Assembly in July that may not open due to the current tax probe over the major press com...
Dongwha's Milikan, an anti-liver cancer drug, approved.
For the 3rd time of its history of domestic new drug development, Dongwha pharmaceutical company obtained the KFDA approval on July 6 over the new anti-liver cancer injectable drug, Milikan.
According to the KFDA...
Business collusion between hospitals and pharmacies to detect strictly.
The MOHW plans to intensify checking any illegal practices including the business collusion between medical institutes and pharmacies along with insurance bill reviews in order to set a soft-landing of the medical and...
